EUHEARING Trademark
EUHEARING is a USPTO trademark filed by Shanghai Euhearing Therapeutics Co., Ltd.. Status: Pending.
Trademark Facts
| Mark | EUHEARING |
|---|---|
| Serial Number | 99163934 |
| Status | Pending |
| Filing Date | 2025-04-30 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 010 (Medical Devices), 042 (Software & IT) |
| Owner | Shanghai Euhearing Therapeutics Co., Ltd. |
| Attorney of Record | Alison M. Caless |
| Prosecution Events | 15 |
| Latest Event | NOAM on 2026-04-14 |
Goods & Services
Liquid medicinal preparations for tinnitus treatment; Medicines for improvement of deafness gene; Medicinal preparations for treatment of deafness; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for gene therapy for the treatment of deafness; medicinal preparations for improving hearing loss; Medicinal infusions for treating hearing loss; In-ear monitors for medical purposes; Ear trumpet; In-ear medicine delivery devices; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments relating to nerve associated with the auditory pathway; Surgical and medical apparatus and instruments for use in otologic microsurgery; Surgical and medical apparatus and instruments for use in general surgery; Injection syringes (syringe barrels); Injection needles; Attachments for medical injection devices to aid in controlling the depth of the injections; Attachments for medical injection devices to aid in stabilizing flow during injection of pharmaceuticals; Syringes for injections; Injection instruments with needles; Injection device for pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing laboratory research services in the field of deafness gene expression; Development of gene-based medicines; Gene therapy research; Research in the field of gene editing technology; Scientific research in the nature of conducting clinical trials for others in the field of deafness treatment; Development of pharmaceuticals for cell and gene therapies; Laboratory research in the field of gene expression; Research and development services in the field of gene expression systems; Testing of pharmaceuticals for cell and gene therapies.
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-02-17 | OG Publication Confirmation | PB3 |
| 2026-02-11 | Notice of Publication | PB1 |
| 2026-02-11 | Notification of Notice of Publication | EB4 |
| 2026-01-23 | TRAM Snapshot of App at Pub for Oppostn | PST |
| 2025-12-19 | Amendment and Mail Process Complete | AMC |
| 2025-12-19 | Response to Office Action | ROA |